Skip to main content

José Raul Herance Camacho

Institutions of which they are part

Head of group
Molecular Imaging and Therapy
Vall Hebron Institut de Recerca

José Raul Herance Camacho

Institutions of which they are part

Head of group
Molecular Imaging and Therapy
Vall Hebron Institut de Recerca

Projects

DIAGNOSTICO POR IMAGEN MOLECULAR: INVESTIGACION BASICA Y DESAROLLO TRASLACIONAL

IP: José Raul Herance Camacho
Collaborators: -
Funding agency: Ministerio de Ciencia e Innovación-MICINN
Funding: 0.01
Reference: RED2022-134299-T
Duration: 01/06/2023 - 31/05/2025

Ministerio de Ciencia

InmunoPET: radiofármacos de diagnóstico in vivo en cáncer

IP: José Raul Herance Camacho
Collaborators: Laia Perez Lasarte, Sergi Velasco Vila
Funding agency: Agència Gestió Ajuts Universitaris i de Recerca
Funding: 37800
Reference: AGAUR/DI2023_3/00124
Duration: 01/03/2024 - 28/02/2027

MARCAJE RADIOACTIVO DE LOS CANALES TRPV4 COMO NUEVA HERRAMIENTA DE DIAGNÓSTICO DE LA FIBROSIS CARDÍACA

IP: Begoña Benito Villabriga
Collaborators: Ignacio Ferreira González, Nuria Rivas Gandara, Antonio Rodríguez Sinovas, Laia Yañez Bisbe, José Raul Herance Camacho, Marisol Ruiz Meana, Javier Inserte Igual
Funding agency: -Sociedad Española de Cardiologia
Funding: 15000
Reference: SEC/FEC-INV-BAS 23/26
Duration: 01/01/2024 - 31/10/2024

Toxicitat cardiovascular en el càncer de mama HER 2-positiu precoç: desde l'avaluació del risc fins a la prevenció

IP: Ignacio Ferreira González
Collaborators: José Antonio Barrabés Riu, Cristina Saura Manich, José Raul Herance Camacho, Gerard Oristrell Santamaria, Javier Limeres Freire, Raul Aguilar Lopez, Filipa Xavier De Carvalho Negrao Valente, Toxicitat cardiovascular en el càncer de mama HER 2-positiu precoç: desde l'avaluació del risc fins a la prevenció, Nuria Coma Auli
Funding agency: Fundació La Marató de TV3
Funding: 198125
Reference: 202311-10
Duration: 11/03/2024 - 10/03/2027

Related news

Researchers incorporate advanced cardiovascular prediction algorithms into cardiac imaging software, enabling the automatic calculation of the risk of serious complications during the routine analysis of cardiac studies.

Researchers from the centre took part in international debates on AI in healthcare, spin-offs emerging from research were presented, and several initiatives linked to VHIR received recognition in the field of entrepreneurship.

ImmunoPET enables in vivo detection of LIF expression, a molecule linked to tumour growth, immune evasion and treatment resistance.

Related professionals

Olalla Bagüés Bedoya

Olalla Bagüés Bedoya

Director/a Àrea
Human Resources Directorate
Read more
Maira Carolina Guzman Solano

Maira Carolina Guzman Solano

Maintenance staff and general services
Infectious Diseases
Read more
Khloud Abdo Soliman Elsharawy

Khloud Abdo Soliman Elsharawy

Postdoctoral researcher
Childhood Cancer and Blood Disorders
Read more
Milagros Mejia

Milagros Mejia

Administration and Management
Cardiovascular Diseases
Read more

Subscribe to our newsletters and be part of the Campus life

We are a world-leading healthcare complex where healthcare, research, teaching and innovation go hand in hand.

CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.